Skip to main content

Table 1 Patient, tumor, and treatment characteristics, and association with radiation-induced lung injury

From: Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy

Characteristic

No. of patients (%)

p value

Gender

 

0.380

Male: Female

48 (84.2): 9 (15.8)

 

Age (y)

 

0.750

≥ 60: < 60

36 (63.2): 21 (36.8)

 

Karnofsky Performance Status

 

0.470

80: >80

13 (22.8): 44 (77.2)

 

Histopathology

 

-

Squamous cell carcinoma

28 (49.1)

 

Adenocarcinoma

20 (35.1)

 

Large cell carcinoma

3 (5.3)

 

NSCLC, not otherwise specified

6 (10.5)

 

Clinical stage

 

1.000

IIIA: IIIB

19 (33.3): 38 (66.7)

 

Smoking history

 

0.702

No: Yes

12 (21.1): 45 (78.9)

 

Chemotherapy

 

0.301

Concurrent: Sequential

17 (29.8): 40 (70.2)

 

Primary tumor location

 

0.087

Upper: Middle and lower lobe

25 (43.9): 32 (56.1)